NRC HEALTH Stockholders Equity

• NRC HEALTH showed a decrease of -55.3% in Stockholders Equity from 2024 to 2025.
• This data is from NRC HEALTH's annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $87.84 million | Q2 2015: $89.70 million | Q3 2015: $86.59 million | Q1 2016: $76.17 million | Q2 2016: $79.66 million | Q3 2016: $81.23 million | Q1 2017: $85.57 million | Q2 2017: $87.83 million | Q3 2017: $88.84 million | Q1 2018: $95.36 million | Q2 2018: $26.82 million | Q3 2018: $30.14 million | Q1 2019: $22.74 million | Q2 2019: $25.97 million | Q3 2019: $28.98 million | Q1 2020: $37.30 million | Q2 2020: $45.57 million | Q3 2020: $56.73 million | Q1 2021: $73.25 million | Q2 2021: $76.37 million | Q3 2021: $83.13 million | Q1 2022: $81.49 million | Q2 2022: $68.62 million | Q3 2022: $67.77 million | Q1 2023: $74.67 million | Q2 2023: $77.75 million | Q3 2023: $57.87 million | Q1 2024: $36.95 million | Q2 2024: $40.20 million | Q3 2024: $34.62 million | Q1 2025: $29.67 million | Q2 2025: $21.33 million | Q3 2025: $14.31 million.
• Over the full 14 years of available data (2012 to 2025), NRC HEALTH's Stockholders Equity has declined by 75.3%.
• Historical annual values: Fiscal year 2025: $13.99 million | Fiscal year 2024: $31.28 million | Fiscal year 2023: $48.96 million | Fiscal year 2022: $72.03 million | Fiscal year 2021: $85.34 million | Fiscal year 2020: $64.32 million | Fiscal year 2019: $32.89 million | Fiscal year 2018: $19.08 million | Fiscal year 2017: $90.04 million | Fiscal year 2016: $82.81 million | Fiscal year 2015: $74.22 million | Fiscal year 2014: $87.75 million | Fiscal year 2013: $71.76 million | Fiscal year 2012: $56.74 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026